Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community

Background: In this work, we aimed to evaluate antibody-response longevity to SARS-CoV-2 infection and/or vaccination in one of the Greek communities that was worst hit by the pandemic, Deskati, five months after a previous serosurveillance and nine months after the pandemic wave initiation (October...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsiou, Ourania S., Papagiannis, Dimitrios, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Vavougios, George D., Kalantzis, Georgios, Gourgoulianis, Konstantinos I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744770/
https://www.ncbi.nlm.nih.gov/pubmed/35010667
http://dx.doi.org/10.3390/ijerph19010407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744770/
https://www.ncbi.nlm.nih.gov/pubmed/35010667
http://dx.doi.org/10.3390/ijerph19010407

Ejemplares similares